Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Concentration is expressed as milligrams per milliliter (mg/mL)
Semaglutide Wegovy / Ozempic Mechanism: GLP-1 receptor agonist (single target) Weight loss: ~15-17% body weight (STEP trials, 68 weeks) Dosing: Weekly injection, titrated from 0.25mg to 2.4mg Common side effects: Nausea, vomiting, diarrhea, constipation (typically transient) Availability: Longer track record, more widely available Cardiovascular data: SELECT trial demonstrated 20% reduction in major cardiovascular events Tirzepatide Zepbound / Mounjaro Mechanism: Dual GLP-1 + GIP receptor agonist (two targets) Weight loss: ~20-22% body weight (SURMOUNT trials, 72 weeks) Dosing: Weekly injection, titrated from 2.5mg to 15mg Common side effects: Similar GI profile to semaglutide
This is your body adjusting to GLP-1 receptor activation in the gut
What is cheaper than BPC-157 for tissue repair
What happens if I develop diabetes while taking compounded tirzepatide
If you miss a dose within five days, take it immediately when you remember
US$ 29.59
%25201.png)
US$ 28.30
US$ 27.85
US$ 24.44
US$ 27.54
